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Wehave previously reported that awell-characterized glycoprotein fraction containing fucose residues in an extract ofGanoderma lucidum
polysaccharides (EORP) exerts certain immuno-modulation activity by stimulating the expression of inflammatory cytokines via TLR4.
Continuing our studies, we have demonstrated that EORP increases the surface expression of CD14 and TLR4 within murine
macrophages J774A.1 cells in vitro, and further promotes LPS binding and uptake by J774A.1 cells in aCD14-dependent fashion.Moreover,
we observed the co-localization of internalized LPS with lysosome- and Golgi-apparatus markers within 5 min after J774A.1 cells
stimulated with LPS. In addition, EORP pretreatment of J774A.1 cells and human blood-derived primary macrophages, followed by LPS
stimulation, results in the super-induction of interleukin-1beta (IL-1) expression. Endocytosis inhibitors: such as cytochalasin D and
colchicine effectively block EORP-enhanced LPS internalization by J774A.1 cells; yet they fail to decrease the LPS-induced phosphorylation
of certainmitogen-activated protein kinases, and IL-1mRNAand proIL-1 protein expression, indicating that LPS internalization by J774A.1
cells is not associated with LPS-dependent activation. Our current results could provide a potential EORP-associated protection
mechanism for bacteria infection by enhancing IL-1 expression and the clearance of contaminated LPS by macrophages.
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DOI: 10.1002/jcp.21050We have previously demonstrated that a glucan-containing
extract of Ganoderma lucidum-derived polysaccharides (EORP),
a charactered polysaccharides containing essential terminal
fucose residues featuring a number of 1, 2-linkages, exerts
immuno-modulation activity by stimulating the expression of
mediators of the normal inflammatory response that occurs
within mouse spleen cells (Wang et al., 2002; Chen et al., 2004),
human blood-derived macrophages and mouse macrophage
cell lines via toll-like receptor 4 (TLR4) (Hsu et al., 2004).
We also demonstrated that EORP enhances CD56þ NK-cell
cytotoxicity within human cord blood (Chien et al., 2004)
and induces immunoglobulin production through the TLR4/
TLR2-mediated induction of transcription factor Blimp-1within
B cells (Lin et al., 2006). TLRs are pattern-recognition receptors
playing a key role in human and murine innate immunity they
detecting microbial infection and following up by triggering
antimicrobial host defense responses (Gordon, 2002;
Iwasaki and Medzhitov, 2004). Gram-negative bacterial
lipopolysaccharide (LPS) is one of potent stimulators of the
normal immune response within certain monocytes and
macrophages (Raetz and Whitfield, 2002). LPS-binding
protein catalyses the transfer of LPS to plasma membranes or
to soluble CD14, which in turn mediate the recognition of
LPS through TLR4 (Goyert et al., 1988), leading to the
transduction of the multiple signaling of the normal
anti-bacterial response, including the production of cytokines
(Poltorak et al., 1998). 2 0 0 7 W I L E Y - L I S S , I N C .
538 H U A E T A L .Phagocytosis is the process, by which macrophages ingest
particulate ligands, and it is a process that is critical for innate
immunity (Stuart and Ezekowitz, 2005). In the course of sepsis,
the processes of physical neutralization and internalization of
LPS by immune cells are important for the detoxification of LPS;
subsequent to endocytosis, LPS is, typically biologically
deactivated by certain specific enzymes (Munford and Hall,
1986). Recently, it has been demonstrated that CD14, but not
TLR4, plays a key role in LPS uptake mechanisms by murine
macrophages (Latz et al., 2002; Dunzendorfer et al., 2004),
whereas for CD14-negative cells, scavenger receptors have
been implicated in the clearance of exogenous LPS (Hampton
et al., 1991). Endocytosis of LPS has been reported to activate
endotoxin-dependent signal transduction within murine
cardiomyocytes (Cowan et al., 2001), whereas for human
monocytic THP-1 cells, LPS-mediated signaling is, reportedly,
independent of LPS internalization (Poussin et al., 1998). It has
been reported previously that polysaccharides purified from
G. lucidum are able to enhance human neutrophil phagocytosis
and chemotaxis (Hsu et al., 2003); however, the effect of G.
lucidum polysaccharides upon LPS endocytosis by macrophages
would appear to be somewhat unclear.
The IL-1 cytokine, involved in several inflammatory and
immunologic processes, is, reportedly, produced by activated
human andmurinemonocytes/macrophages, as well as bymany
other cell types (Dinarello, 1996). A precursor form of IL-1,
referred to as proIL-1, is, reportedly, translated from IL-1
mRNA and cleaved into a 17-kDa mature secreted form of IL-1
by interleukin-1 converting enzyme (ICE) (Cerretti et al., 1992).
IL-1 represents a potent inflammatory cytokine featuring
numerous biological activities that regulate host defense and
immune responses (Loppnow et al., 1998). Mice pretreated
with recombinant IL-1 prior to infection with Escherichia coli
reveal significantly reducedmortality rates comparedwithmice
that do not undergo such pretreatment (Joshi et al., 2002). The
potentially beneficial functions of IL-1, however, do require
some modulation, on occasion, in order to avoid causing
serious damage including shock and organ failure associated
with sepsis (Waage and Espevik, 1988), and joint inflammation
for cases of rheumatoid arthritis (Kay and Calabrese, 2004)
following the administration or overexpression of IL-1 to the
individual. One of the endogenous forms of modulation of IL-1
activity is achieved via the production of interleukin-1 receptor
antagonist (IL-1Ra), a member of the IL-1 family and one which
binds to IL-1 receptors, but does not induce any intracellular
response compared to IL-1 stimulation (Hannum et al., 1990).
Studies involving transgenic and knockout mice indicate that
IL-1Ra is important for the normal host defense against
LPS-induced injury in mice (Hirsch et al., 1996).
In order to examine the impact of EORP upon LPS endocytosis
and LPS-dependent cytokine expression,we have used confocal
microscopy and flow cytometry to demonstrate that EORP
enhances CD14 and TLR4 surface expression and promotes
LPS endocytosis within cultured murine macrophages. In
addition, we have used mice and a specific macrophage
model to present the evidence that IL-1Ra expression was
increased upon EORP injection and stimulation, respectively, as
well as enhancing LPS-induced activation of ERK, JNK, and p38,




Using Histopaque1-1077 method, human blood monocytes-derived
macrophages were isolated from blood of healthy persons obtained
from Taiwan Blood Center (Taipei, Taiwan). J774A.1 cells were
obtained from ATCC (Rockville, MD). All cell cultures were
propagated in RPMI 1640 medium supplemented with 10%JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPheated-inactivated fetal bovine serum and 2mML-glutamine and
cultured in a 378C, 5% CO2 incubator.
Study of IL-1 production challenged with LPS and EORP
in mice model
Male C57BL/6J mice (8–10 weeks old and averaged 18–22 g) were
purchased from National Laboratory Animal Center (Taipei, Taiwan).
All animal procedures were conducted under a license from the
Institutional Animal Care and Use Committee at the National
Yang-Ming University. Mice were intra-peritoneal injected of 100 mg/
kg EORP, 5 mg/kg LPS or an equal volume (200 ml) of PBS 24 h before
10 mg/kg LPS or 200mg/kg EORP challenges. Sera were collected after
LPS or EORP challenge for assessment of IL-1 and TNF expression.
Materials
LPS, FITC-LPS (from E. coli 0111:B4), Histopaque1-1077, anti-MAP
kinase, activated (diphosphorylated ERK) antibody, anti-JNK kinase,
activated (diphosphorylated JNK) antibody, anti-p38 MAP kinase,
activated (diphosphorylated p38) antibody, and anti-actin antibody
were purchased from Sigma Co. (St. Louis, MO). Anti-rabbit IgG-HRP,
anti-mouse IgG-HRP, and anti-IL-1 antibody were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA); anti-mouse TLR4 blocking
antibody and PE-conjugated anti-mouse TLR4 antibody were obtained
from IMGENEX Corporation (Carlsbad, CA); PE-conjugated anti-
mouse CD14 antibody was obtained from BD Biosciences (Mountain
View, CA); anti-mouse macrophage scavenger receptor (MSR)
antibody (2F8) and FITC-conjugatedMSR antibodywere obtained from
Serotec, Inc. (Oxford, UK). Mouse IL-1 Enzyme-Linked
Immunosorbent Assay (ELISA) Kit was purchased from R&D Systems,
Inc. (Minneapolis, MN). Human IL-1 and TNF ELISA Kit were
purchased from BioSource International, Inc. (Camarillo, CA). Primers
for RT-PCR of IL-1 and glyceraldehydes phosphate dehydrogenase
(GAPDH) were synthesized from MDBio. Inc. (Taipei, Taiwan). The
LysoTrackerTM Red DND-99 and BODIPY TR C5-ceramide were
purchased from Molecular Probes, Inc. (Eugene, OR).
Preparation of EORP, RNA isolation, RT and PCR amplification
for detecting the expression of IL-1, Western Blotting Analysis,
ELISA for measurement of IL-1 and ICE activity assay
All detail methods and procedures were followed the previous
methods (Hsu et al., 2004).
Flow cytometric analysis
For cell surface expression experiments of TLR4, CD14, and MSR,
J774A.1 cells were incubatedwithmedium (control), EORP (25mg/ml),
LPS (1 mg/ml), fucoidan (25 mg/ml), F1 fraction of Reishi (25 mg/ml), or
F2 fraction of Reishi (25 mg/ml) for 24 h. Cells were fixed and cell
surface expression of TLR4, CD14 or MSR were measured by staining
cells for 30 min with PE-conjugated anti-TLR4 antibody, PE-conjugated
anti-CD14 antibody, or FITC-conjugated MSR antibody on ice,
respectively. After washing, cells were subjected to flow cytometric
analysis on FACSCalibur using CellQuest Software of Becton
Dickinson Inc. (San Jose, CA). Experiments for binding of LPS to cell
surface, J774A.1 cells were incubated with medium, EORP (25 mg/ml)
or LPS (1 mg/ml) for 24 h. After fixation, cells were incubated with
FITC-LPS for 30min at 48C.Afterwashing, cells were subjected to flow
cytometric analysis. For LPS uptake experiments, J774A.1 cells were
incubated with medium, EORP (25 mg/ml) or LPS (1 mg/ml) for 24 h.
After washing, cells were incubated with FITC-LPS for 1 h at 378C.
After incubation, cells were washed twice with PBS and further treated
with proteinase K (250 mg/ml) for 30 min at room temperature to
remove cell surface proteins/receptors and surface-bound LPS
(Kitchens and Munford, 1998). The remaining LPS were considered to
be intracellular and FITC-LPS in J774A.1 cells were measured by flow
cytometric analysis.
Confocal microscope analysis
For LPS cell surface binding experiments, J774A.1 cells were incubated
with medium or EORP (25 mg/ml) for 24 h. Cells were fixed and
incubated with TLR4 blocking antibody (10 mg/ml), CD14-blocking
antibody (10 mg/ml), or control antibody (10 mg/ml) for 30 min,
followed by incubation of FITC-LPS for 30 min at 48C. For LPS uptake
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for 24 h. After washing, cells were incubated with TLR4 blocking
antibody (10 mg/ml), CD14-blocking antibody (10 mg/ml), control
antibody (10mg/ml), cytochalasinD (10mM) or colchicines (30mM) for
30 min, followed by incubation of FITC-LPS for 1 h at 378C. For TLR4
and CD14 expression, cells were incubated with EORP (25 mg/ml) for
24 h, followed by staining with PE-conjugated anti-TLR4 antibody or
PE-conjugated anti-CD14 antibody for 2 h at room temperature. For
TLR4/Golgi and CD14/Golgi co-localization experiments, cells were
incubated with medium or EORP (25 mg/ml) for 24 h. After washing,
cells were incubated with BODIPY TR C5-ceramide (1 mM) at 48C for
30 min, followed by stained with FITC-conjugated TLR4 or CD14
antibody at 48C for additional 2 h. For LPS/lysosomes and LPS/Golgi
co-localization experiments, cells were incubated with EORP (25 mg/
ml)
for 24 h. After washing, cells were incubated with LysoTrackerTM
RedDND-99 (10 nM) or BODIPYTRC5-ceramide (1mM) at 37 and 48C
for 30min, respectively, followed by FITC-LPS (1mg/ml) stimulation for
0–30 min. After washing, cells were visualized using a Leica TLS SP2
confocal microscope (Leica Lasertechnik, Heidelberg, Germany).
Statistical analysis
Statistical differences between the experimental groups were
examined by analysis of variance, and statistical significance was
determined at P< 0.05. The experiments were conducted three times
or as indicated, all data are expressed as mean SE.Fig. 1. EORP increases surface expressionof TLR4 andCD14within J774A
LPS (1 mg/ml), fucoidan (25 mg/ml), F1 fraction of Reishi (25 mg/ml) or F2 f
followedbystainedwithPE-conjugatedTLR4orCD14antibody for30min,
shade histograms: treatment as indicated. The histograms were quantifie
were incubated with medium or EORP (25 mg/ml) for 24 h, followed by st
by confocal microscope. C: J774A.1 cells were labeled with BODIPY TR C
paraformaldehydeandpermeatedwith0.1%TritonX-100, cellswerestaine
confocalmicroscope.Merged images of Golgimarker andTLR4 orCD14 a
which is available at www.interscience.wiley.com.]
JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPResults
EORP increases macrophage-membrane surface
expression of TLR4 and CD14
The activation and modulation of TLR4 is an important early
step in either EORP- (Hsu et al., 2004) or LPS-mediated signal
transduction in the regulation of IL-1 gene expression (Hsu and
Wen, 2002), thus we were interested in examining the effect of
EORP (i.e., fraction 3, F3) upon TLR4 surface expression.
Initially, using flow cytometry analysis, we demonstrated that
EORP specifically up-regulates cultured murine macrophages
J774A.1 cells surface expression of TLR4 as indicated by mean
fluorescence intensity (MFI) (Fig. 1A, left part), although this is
not the case for any of the other Reishi polysaccharide
F3-relevant fractions (e.g., fractions 1 and 2, F1 and F2) (Wang
et al., 2002), nor is it the case for fucoidan, a principal fucose
polysaccharide sulfate ester found in brown seaweeds,
Phaeophyceae species (Hsu et al., 2001). By contrast, we found
that LPS treatment down-regulates J774A.1 cells surface
expression of TLR4 (Fig. 1A, left part), an observation, which is
similar to that, reported in another LPS tolerance study
featuring cultured murine macrophage cells RAW264.7
(Nomura et al., 2000). In the following investigation, while
examining the cell membrane expression of CD14, which
involved, importantly, LPS-mediated signaling, we found that.1 cells. A: J774A.1 cellswere incubatedwith oneof EORP (25mg/ml),
raction of Reishi (25 mg/ml) for 24 h, fixed with 2% paraformaldehyde,
thenanalyzedbyflowcytometry.Dotted line: isotypecontrolantibody;
d and represent asmean fluorescence intensity (MFI). B: J774A.1 cells
ained with PE-conjugated TLR4 or CD14 antibody, then analyzed
5-ceramide (1 mM) at 4-C for 30 min followed by fixed with 2%
dwithFITC-conjugatedTLR4orCD14antibody,andthenanalyzedby
re indicated by arrows. [Color figure can be viewed in the online issue,
Fig. 1. (Continued )
540 H U A E T A L .EORP significantly increases CD14 surface expression
(Fig. 1A, right part); but that there was no such analogous effect
of LPS, F1, F2, and fucoidan upon CD14 expression. Moreover,
using confocal microscopy, we further confirmed that only
EORP, and no other above-mentioned polysaccharides, is able
to increase the surface expression of TLR4 and of CD14 by
J774A.1 cells (Fig. 1B). It has been reported that TLR4 is
localized to the Golgi apparatus within murine small intestinal
epithelial cells (Hornef et al., 2002). To identify the cytoplasmic
compartment harboring TLR4 within macrophages, double
immuno-fluorescent staining was performed using BODIPY
TR C5-ceramide, a fluorescent structural marker for Golgi
complex, and FITC-conjugated TLR4 antibody. Markers of
the Golgi complex BODIPY TRC5-ceramide showed a partially
co-localization with TLR4 staining (Fig. 1C), suggesting a
widespread distribution of TLR4 in theGolgi complex. Also, we
found CD14 is partial harboring in the Golgi complex within
J774A.1 cells (Fig. 1C). In addition, MSR is considered to be a
binding receptor of LPS (Hampton et al., 1991), yet
interestingly, we found that EORP decreases J774A.1 cell
surface expression of MSR, however, LPS was also observed to
up-regulate J774A.1 cell surface expression of MSR (data not
shown).
EORP enhances LPS recognition/binding affinity
and LPS uptake/clearance within macrophages
It has been previously reported that Reishi polysaccharides
enhance neutrophil phagocytosis (Hsu et al., 2003). Here weFig. 2. EORP increases LPSbinding and internalization by J774A.1 cells. A
followedbyfixedwith 2%paraformaldehyde.Cellswere incubatedwith con
blocking antibody (10mg/ml) for 30min, followed by incubatedwith FITC-L
microscope. PartA: phase contrast images; partB: fluorescent images; par
binding to J774A.1 cells. J774A.1 cells were incubated with medium, EOR
paraformaldehyde. Cells were incubated with FITC-LPS (1 mg/ml) at 4-C
FITC-LPS control; shade: treatment as indicated. The histogramswere qu
pretreatment increases LPS internalization by J774A.1 cells. J774A.1 cel
washing, cells were incubated with control antibody (10 mg/ml), TLR4 blo
30min, followed by incubatedwith FITC-LPS (1mg/ml) (green) at 37-C for
examined by confocal microscope. Part A: phase contrast images; part B
specifically increases LPS internalization by J774A.1 cells. J774A.1 cells w
(25 mg/ml), F1 fraction of Reishi (25 mg/ml), and F2 fraction of Reishi (25
37-C for 1 h. After proteinase K (250 mg/ml) treatment, cells were analy
histograms: treatment as indicated. The histograms were quantified and
viewed in the online issue, which is available at www.interscience.wiley.c
JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPexamined whether EORP pretreatment of J774A.1 cells affects
LPS recognition/binding and uptake/clearance by J774A.1 cells.
Initially, using confocal microscopy to observe the results of an
LPS binding assay, we found that subsequent to the incubation
of FITC-conjugated LPS (FITC-LPS) with fixed J774A.1 cells at
48C for a period of 30min, the amountof cell surface-bound LPS
was substantially greater for EORP-pretreated J774A.1 cells
(Fig. 2A, part C-2), than was the case for medium-pretreated
J774A.1 cells, that is, control cells (Fig. 2A, part C-1). Following
this work, we analyzed the role of TLR4 and that of CD14 in LPS
recognition/binding by J774A.1 cells. As can be seen,
pretreatment of J774A.1 cells with CD14 blocking antibody
(Fig. 2A, part C-4), but not with TLR4 blocking antibody
(Fig. 2A, part C-3) prior to FITC-LPS stimulation resulted in
significantly reduction of LPS binding to J774A.1 cells surface,
indicating that CD14 plays a more important role than TLR4 in
LPS binding to J774A.1 cells. In addition, using flow cytometry
analysis, we further confirmed that pretreatment of J774A.1
cells with EORP, but not LPS, enhances FITC-LPS binding to the
cell surface of J774A.1 cells (Fig. 2B).
Alternatively, in order to examine the effect of EORP upon LPS
uptake/clearance, we first pretreated J774A.1 cells with EORP
or medium (control), followed by incubation of J774A.1 cells
with FITC-LPS at 378C for a period of 1 h. Under confocal
microscopy-assisted analysis of the endocytosis of FITC-LPS,
we found that EORP significantly increases J774A.1 cells
FITC-LPS uptake/clearance (Fig. 2C, part C-2), compared to
analogous cells treatedwithmedium alone (Fig. 2C, partC-1). In
subsequent investigation, we further demonstrated that the: J774A.1 cells were treatedwithmediumorEORP (25mg/ml) for 24 h
trol antibody (10mg/ml), TLR4blocking antibody (10mg/ml), orCD14
PS (1mg/ml) (green) at 4-C for 30min, and then examined by confocal
tC:merged images. B: EORP, but notLPSpretreatment increase LPS
P (25 mg/ml) or LPS (1 mg/ml) for 24 h followed by fixed with 2%
for 30 min, and then examined by flow cytometry. Dotted line: no
antified and represent asmean fluorescence intensity (MFI). C: EORP
ls were incubated with medium or EORP (25 mg/ml) for 24 h. After
cking antibody (10 mg/ml) or CD14 blocking antibody (10 mg/ml) for
1 h. After fixation and proteinase K (250mg/ml) treatment, cells were
: fluorescent images; part C: merged images. D: EORP pretreatment
ere incubated with one of EORP (25 mg/ml), LPS (1 mg/ml), fucoidan
mg/ml) for 24 h, followed by incubation with FITC-LPS (1 mg/ml) at
zed by flow cytometry. Dotted line: no FITC-LPS control; shade
represent as mean fluorescence intensity (MFI). [Color figure can be
om.]
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blocking antibody (Fig. 2C, part C-3) blocks LPS uptake/
clearance by J774A.1 cells significantly, indicating that CD14
plays a more-important role than TLR4 in the endocytosis of
LPS within J774A.1 cells. Furthermore, using flow-cytometry
analysis, we also confirmed that pretreatment of J774A.1 cells
with EORP enhances FITC-LPS uptake/clearance by J774A.1Fig. 2
JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPcells; and, in addition, LPS pretreatment enhances FITC-LPS
uptake/clearance by J774A.1 cells, although by only a slight
amount. Pretreatment of other EORP-related polysaccharide
fractions, for example, F1 and F2, and fucoidan, however,
did not increase LPS uptake/clearance, indicating that EORP
(i. e., F3) specifically facilitates macrophages uptake/clearance
of LPS (Fig. 2D)..
542 H U A E T A L .Co-localization of internalized LPS with lysosome and
Golgi apparatus markers
It has been demonstrated previously that internalized LPSmove
transiently into an acidic intracellular compartment of human
neutrophils (Munford and Hall, 1986). In our current study, in
order to examine whether LPS alsomoves into lysosomes after
uptake by J774A.1 cells, we used a fluorescent, freely cell
membrane permeable probe, LysoTrackerTM Red DND-99
(LysoTracker), which features a high selectivity for acidic
organelles (Via et al., 1998). LysoTracker-prelabelled J774A.1
cells were incubated with FITC-LPS at 378C for various periods
of time, including: 0, 5, 15, and 30 min; followed by observation
under confocal microscopy while cells were still viable.
Endocytosis-mediated internalized LPS can be detected as early
as 5 min and subsequent to a 30- min period of LPS
internalization subsequent to initial stimulation
(Fig. 3A, samples A1–A4). LPS was detected in a perinuclear
area of J774A.1 cells and distributed in a tubular pattern afterFig. 3. Co-localization of internalized LPS with lysosome and Golgi appa
markerswithin J774A.1 cells.Markers of (A) lysosome (LysoTracker) or (B
min and processed for microscopy. Part A: fluorescence for LPS alone; Pa
organelle marker as indicated by arrows. [Color figure can be viewed in t
JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPuptake by J774A.1 cells, an observation which is similar to that
reported in LPS uptake by murine peritoneal macrophages
(Thieblemont and Wright, 1997); yet by contrast, the
fluorescent lysosomes were distributed throughout the
cytoplasm of J774A.1 cells (Fig. 3A samples B1–B4). The results
of merging FITC-LPS and LysoTracker processes revealed that
the test cell cellular compartment containing the internalized
FITC-LPS partially overlapped the lysosomes (Fig. 3A, samples
C1–C4).On the other hand, theGolgi apparatus of test J774A.1
cells could be selectively stainedwith a fluorescent dyeBODIPY
TR C5-ceramide (BODIPY), which tends to associate
preferentially with the trans-Golgi complex (Lipsky and Pagano,
1985). The results of cellular staining assay showed that the
punctuate pattern of labelled cells appeared to be similar when
stained with either LPS or BODIPY, and that the brightly
labelled LPS-containing vesicles colocalized with BODIPY
fluorescence during the above-mentioned FITC-LPS uptake
assay period of from 0 to 30 min at 378C (Fig. 3B, samples
C1–C4). Comparing the fluorescence intensity in the Golgiratus markers. Intracellular distribution of LPS and organelle
)Golgi (BODIPY-Cer)were incubatedwith FITC-LPS at 37-C for 0–30
rt B: the organelle marker alone; Part C: merged image of LPS and
he online issue, which is available at www.interscience.wiley.com.]
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in corresponding lysosomes, there would appear to be a
stronger co-localization of FITC-LPS and Golgi apparatus,
suggesting that more FITC-LPS molecules accumulate in the
Golgi apparatus of J774A.1 cells after FITC-LPS being
internalized than congregate within lysosomes. Based upon the
current observations showed in Figure 3, vesicular transport
from the plasma membrane of J774A.1 cells appears to deliver
FITC-LPS to the Golgi apparatus and also to the lysosome,
however, other delivery sites for fluorescent-labeled LPS
probably also include endosomes and the endoplasmic
reticulum of J774A.1 cells after LPS internalization (Kriegsmann
et al., 1993), both of which delivery-site options warranting
further investigation.
EORP increases IL-1 secretion within LPS-stimulated
human primary macrophage and within murine
macrophage J774A.1 cells
From our investigations, we observed that pretreatment of
J774A.1 cells with EORP or a mixture of EORP and LPS (EORP/
LPS) followed by incubation with LPS for a period of 24 h,
significantly increased IL-1 secretion by J774A.1 cells compared
to the case for EORP-free controls (Fig. 4A, samples 3 and 4 vs.
1 and 2). From the results of an EORP dose–response study of
J774A.1 cells, if the concentration of EORP pretreatment of
J774A.1 cells was greater than 25 mg/ml for 24 h, such
pretreatment resulted in the LPS-mediated hyperesponsiveness
of IL-1 secretion from J774A.1 cells (Fig. 4B). Following such
experimentation, we found that pretreatment of either human
primarymacrophages or J774A.1 cells (Fig. 4C)with EORP for a
period of 24 h substantially increased LPS-induced IL-1
secretion compared to the case for EORP-free controls.
Moreover, within 24 h of EORP pretreatment, IL-1 secretion
into culture supernatant from cultured human macrophages
and murine J774A.1 cells was observed to be, respectively,
25 ng/ml and 1 ng/ml, indicating different reaction kinetics as
regards IL-1 secretion apply for human macrophages and
J774A.1 cells.
Preinjection of EORP increases IL-1 secretion
for LPS-injected mice in vivo
As part of our further investigation, we tested the in vivo effect
of EORP upon LPS-induced cytokine expression for C57BL/6J
mice. In brief, C57BL/6J mice were initially injected
intraperitoneally (i.p.) with one of the following, PBS, LPS or
EORP. Twenty-four hours subsequent to such injection, mice
were again i.p. injected with PBS, LPS, or EORP, 1.5 h following
which, the concentration of IL-1 in the serumof the testedmice
wasmeasured bymeans of ELISA (Fig. 4D). Themice initially i.p.
injectedwith PBS, EORP, or LPSwere defined as groupA, group
B, and group C, respectively. Group A mice (Fig. 4D, samples
1–3), revealed that a second LPS injection increased the
baseline level of IL-1 secretion by C57BL/6J mice (550 pg/ml,
sample 3) more substantially than was the case for EORP
injection (100 pg/ml, sample 2) or for PBS injection (control)
mice (basal level, sample 1). For group B, mice were initially i.p.
injectedwith EORP for 24 h, followedby a second injectionwith
one of PBS, EORP, or LPS for 1.5 h (samples 4–6, respectively).
The results of such treatment indicated that EORP significantly
increased LPS injection-induced IL-1 secretion from mice
(800 pg/ml, sample 6), such increase in IL-1 secretion not
being the case for mice injected with either EORP (50 pg/ml,
sample 5) or PBS (basal level, sample 4) as the second injection.
For groupC,micewere initially injectedwith LPS for a period of
24 h, followed by again injection with one of PBS, EORP or LPS
(samples 7–9, respectively). A second injection of LPS induces
lower IL-1 secretion in mice serum (400 pg/ml, sample 9)
compared to the case for single LPS injected mice (group A,JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPsample 3). By contrast, EORP and PBS injection did not induce
significantly IL-1 secretion in mice serum (samples 6 and 7).
Although EORP was observed to increase LPS-induced IL-1
expression by J774A.1 cells, it did not increase the relative
toxicity of LPS C57BL/6J mice (data not shown), thus we tested
the hypotheses that EORP was able to stimulate some sort of
‘‘protection’’ factors from cultured J774A.1 cells. We
investigated whether it was possible for EORP to increase the
level of IL-1 receptor antagonist (IL-1Ra) expression. As can be
seen from Figure 4E, there appears to be no evidence of the
presence of IL-1Ra in the serumof PBS-injectedmice or control
mice. By contrast, however, at 3 h post-EORP injection of test
mice, we noted that IL-1Ra concentration in mice serum was
substantially induced by the injection of EORP, the level of
IL-1Ra reaching to around 5,000 pg/ml in mice serum 3 h
subsequent to EORP injection, although we also observed
that LPS injection into C57BL/6J mice increased IL-1Ra
concentration in serum. In addition, EORP treatment also
increases IL-1Ra secretion from cultured J774A.1 cells and
human primary macrophages (data not shown).
Mechanism by which the pretreatment of
macrophages with EORP increasing LPS-induced
proIL-1/IL-1 expression
In order to investigate the mechanism of EORP boosting
LPS-induced IL-1 secretion by J774A.1 cells, initially, we
examined the effect of EORP pretreatment upon proIL-1
protein production by J774A.1 cells subjected to subsequent
LPS stimulation. Prointerleukin-1 (proIL-1, 34 kDa), an IL-1
precursor is translated from IL-1 mRNA and cleaved into a
mature secreted form of IL-1 (17 kDa) by interleukin-1-
converting enzyme (ICE) (Cerretti et al., 1992). Pertaining to
such a pathway, we first investigated proIL-1 protein
production within J774A.1 cells using Western-blotting
analysis. Resulting from time-course study, proIL-1 production
was detected in cell lysate between 3 and 9 h subsequent to LPS
stimulation, the proIL-1 protein level peaking at 6 h, the proIL-1
protein level in cell lysate gradually returning to the basal level at
around 12 h subsequent to LPS stimulation (Fig. 5A). By
contrast, for J774A.1 cells pretreated with EORP, followed by
LPS stimulation, the level of proIL-1 protein expression was
greater for such pretreated cells than was the case for un-
pretreated J774A.1 cells (Fig. 5A). Following such investigation,
we attempted to determine the necessary EORP incubation
time for cultured J774A.1 cells so as allowing them to develop
the ‘‘hyper-induction’’ of proIL-1 protein expression. In brief,
during a 24 h period, at various specific times (i.e.
commencement, 1, 3, 6, 12, 18, and 24 h subsequent to EORP
pretreatment), such EORP pretreatment of J774A.1 cells was
halted by washing with PBS, followed by LPS challenge for an
additional 6 h. Following this, Western-blotting analysis of
proIL-1 production indicated that a minimum pretreatment of
J774A.1 cells with EORP for a period of around 3–6 h was
required to induce ‘‘hyper-induction’’ of proIL-1 protein
expression (Fig. 5B). Furthermore, in order to investigate
whether EORPmodulates LPS-induced IL-1 gene expression at
the transcriptional level, the IL-1 mRNA expression level was
analyzed by RT-PCR method. Resulting from such
experimentation, we found that LPS-induced IL-1 mRNA
expression for EORP-pretreated J774A.1 cells were greater
thanwas the case for un-pretreated counterpart cells (Fig. 5C).
EORP pretreatment up-regulates LPS-induced
proIL-1/IL-1 expression via activation of
mitogen-activated protein kinases (MAPKs)
In order to further investigate the effect of EORP upon
LPS-mediated signaling related to IL-1 gene expression, we
examined whether EORP pretreatment of J774A.1 cells alters
Fig. 4.
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Fig. 5. Pretreatment of J774A.1 cells to EORP increases LPS-induced IL-1 gene expression. A: J774A.1 cells were pretreated with EORP
(25mg/ml) ormedium for 24 h, and then challengedwith LPS (1mg/ml) for the indicated time points. ProIL-1 protein productionwas analyzed by
Western blotting; nU 3. B: J774A.1 cell were pretreatedwith EORP for the indicated time points prior to LPS stimulation for 6 h. ProIL-1 protein
production was analyzed by Western blotting; nU 4. C: J774A.1 cells were pretreated with EORP (25 mg/ml) or medium for 24 h, and then
stimulated with LPS (1 mg/ml) for the indicated time points. IL-1 and GAPDH mRNA expression level were analyzed by RT-PCR; nU 3.
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demonstrated that LPS rapidly induced the activation of ERK,
JNK, and p38 (Fig. 6A, samples 1–7); whereas, by contrast, pre-
exposure of J774A.1 cells to EORP resulted in the rapid and
substantial enhancement of the LPS-mediated activation of
ERK, JNK, and p38 (Fig. 6A, samples 8–14). More specifically, in
the first instance, the phosphorylation level of ERK reached a
peak at around 20 min subsequent to LPS stimulation, and
returned to the basal level at around 60 min subsequent to LPS
stimulation. Further, the phosphorylation level of ERK was
increased again at 240 and 360 min subsequent to LPS
stimulation. Interestingly, for EORP-pretreated J774A.1 cells,
the phosphorylation level of ERK proved to be, 1.5-, 3-, 6-, 5-,
2.5-, and 1.5-fold greater than corresponding values for EORP-
free cells at, respectively, 20, 40, 60, 120, 240, and 360 min
subsequent to LPS stimulation (Fig. 6A). The presence of
phosphorylated JNK at a significant level above baseline was
detected at around 20 min subsequent to LPS stimulation,
whereas the level of LPS-induced JNK phosphorylation
increased to only a slight extent for the EORP-pretreated
J774A.1 cells (Fig. 6A). The phosphorylation level of p38 quickly
reached the maximal level at around 20 min subsequent to LPS
stimulation, the level reducing significantly 40 min subsequent
to LPS stimulation, although p38 phosphorylation again began
to rise at around 240–360 min subsequent to LPS stimulation.
For EORP-pretreated J774A.1 cells, the phosphorylation level
of p38 following LPS stimulation was, one-, four-, two-, three-,Fig. 4. EORPpretreatment increases IL-1 secretion fromLPS-stimulated
(1T 106/ml) were pretreatedwith EORP (25mg/ml), EORP (25mg/ml) plus
LPS (1 mg/ml) for 24 h. IL-1 concentration in culture supernatant wasmea
B: J774A.1 cells (1T 106/ml) were pretreatedwith the indicated concentra
IL-1 concentration in culture supernatant was measured by ELISA. Data
monocytes-derived macrophages (5T 105/ml) and J774A.1 cells (1T 106/
24 h, then challenged with LPS (1 mg/ml) for the indicated time points. I
Data shownhereexpressedas themeanWSD,nU 4.D:C57BL/6Jmicewer
(200 ml), LPS (5 mg/kg) or EORP (100 mg/kg). Twenty-four hours subsequ
LPS (10mg/kg) or EORP (200mg/kg); 1.5 h following which, the concentra
ELISA; nU 6. E: C57BL/6J mice were initially injected i.p. with one of the
following which, the concentration of IL-1Ra in the serum of the tested m
JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPand two-fold greater than the corresponding level for
un-pretreated J774A.1 cells at, respectively, 20, 40, 60, 120, and
240min subsequent to LPS stimulation (Fig. 6A). In addition, we
employed three pharmacological protein kinase (PK) inhibitors,
to further assess the correlation between the EORP-enhanced
activation of studied MAPKs and the corresponding cytokine
expression. Following EORP pretreatment and prior to LPS
treatment, J774A.1 cells were incubated with one of PD98059,
SP600125- or SB203580, agents which specifically inhibit
the activity of, respectively, MEK1, JNK, and p38. The dose–
response performance for the specific PK inhibitors tested was
monitored by directly assaying individual PK activity (Hsu and
Wen, 2002). As can be seen from Figure. 6B, application of the
JNK inhibitor (SP600125) and the p38 inhibitor (SB203580)
significantly blocked EORP enhancement of LPS-induced proIL-
1 protein expression. The application of PD98059 (a MEK1
inhibitor), however, did not appear to diminish LPS-induced
proIL-1 protein expression for EORP-pretreated J774A.1 cells
(Fig. 6B), indicating that the pathway of MEK1 ! ERK plays a
less-significant role than JNK and p38 related pathways as
regards the induction of proIL-1. Furthermore, as measured by
application of an MTT assay, no evidence of a cytotoxic effect
was observed subsequent to J774A.1 cells treatmentwith any of
the PK inhibitors, at the specific concentrations at which these
inhibitors were used (data not shown). Taken together, our
current results indicate that EORP pretreatment of cultured
J774A.1 cells up-regulates LPS recognition and clearance byhumanprimarymacrophages, J774A.1cells andmice.A: J774A.1cells
LPS (1mg/ml) ormedium (control) for 24 h, and then challengedwith
sured by ELISA. Data shown here expressed as themeanWSD, nU 3.
tion of EORP for 24 h, and then challengedwith LPS (1mg/ml) for 24 h.
shown here expressed as the meanWSD, nU 4. C: Human blood
ml) were pretreated with EORP (25 mg/ml) or medium (control) for
L-1 concentration in culture supernatant was measured by ELISA.
e initially injected intraperitoneally (i.p.)withoneof the following, PBS
ent to such injection, mice were again i.p. injected with PBS (200 ml),
tion of IL-1 in the serumof the testedmicewasmeasured bymeans of
following, PBS (200 ml), LPS (10 mg/kg), or EORP (200 mg/kg); 3 h
ice was measured by means of ELISA; nU 6.
Fig. 6. EORP pretreatment up-regulates LPS-induced proIL-1/IL-1
expression via activation of mitogen-activated protein kinases
(MAPKs). A: EORP pretreatment up-regulates LPS-induced MAPKs
phosphorylation. J774A.1 cells were pretreated for 24 h with EORP
(25 mg/ml) or medium and challenged with LPS (1 mg/ml) for the
indicated time points. Phosphorylation level of ERK, JNK, and p38
were analyzed byWestern blotting with anti-diphosphorylated ERK,
anti-diphosphorylated JNK or anti-diphosphorylated p38monoclonal
antibody, respectively. One of three experiments is presented.
B: J774A.1 cells were pretreated for 24 h with EORP (25 mg/ml) or
medium and stimulated with LPS (1 mg/ml) for the indicated time
points in the present or absence of protein kinase inhibitors as
indicated. ProIL-1 protein expression level was analyzed byWestern
blotting. One of three experiments is presented.
546 H U A E T A L .J774A.1 cells as well as the activation of certain MAPKs, leading
to proIL-1/IL-1 expression.
Effect of LPS uptake/internalization upon LPS-mediated
activation and signaling related to IL-1 gene expression
In the presence or absence, individually, of the endocytosis
inhibitors cytochalasin D (Cooper, 1987) and colchicine (Isowa
et al., 1999), cultured J774A.1 cells were preincubated with
EORP, we subsequently examining the effect of such
endocytosis inhibitors upon EORP-induced LPS uptake/
internalization. As can be seen from confocal microscopy
investigation (Fig. 7A), the presence of cytochalasin D (sample
C-3) and also that of colchicine (sample C-4) significantly
blocked the internalization of FITC-LPS compared with the
analogous results for cytochalasin D/colchicine-free cells
(Fig. 7A, samples C-2). Thus, in order to further investigate
the presumed relationship between endocytosis-mediated LPS
uptake/internalization and LPS-dependent activation of
signaling related to IL-1 gene expression within J774A.1 cells.
In essence, we analyzed both the LPS-induced downstreamJOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPactivation of test MAPKs and also IL-1 gene expression by
J774A.1 cells in the presence, separately, of the endocytosis
inhibitors, cytochalasin D and colchicine. Binding of LPS to
J774A.1 cells quickly induces phosphorylation of the MAPKs
(ERK, JNK, and p38) (Fig. 7B, sample 2). Although endocytosis
inhibitors such as cytochalasin D and colchicine both exerted
profound inhibitory effects upon LPS uptake/internalization
(Fig. 7A, samples C-3 and C-4), their effects upon J774A.1 cells
activation and signaling would appear to be quite different. For
example, both cytochalasin D and colchicine enhance p38
phosphorylation, and cytochalasin D up-regulates the
phosphorylation level of ERK1/2, whereas colchicine acts to the
contrary, it diminishing the phosphorylation level of ERK1/2
(Fig. 7B). When comparing such activity with LPS treatment
of cultured J774A.1 cells, cytochalasin D ‘‘super’’-induces
LPS-mediated proIL-1 production, whereas, by contrast,
colchicine exerts a significantly lower impact upon proIL-1
induction. Further, at a relatively substantial concentration
(30 mM), colchicine actually inhibits proIL-1 production
(Fig. 7C). Moreover, using RT-PCR method, we further
examined the effect of cytochalasin D and colchicine upon IL-1
mRNAexpression. As can be seen from Figure 7D, therewould
not appear to be any significant difference in IL-1 mRNA
expression between the treatment of cultured J774A.1 cells
with cytochalasin D, colchicine or LPS, either with or without
EORP pretreatment (Fig. 7D). At reasonably large doses,
colchicine inhibited proIL-1 protein production but did not
affect IL-1 mRNA expression, suggesting that colchicine
interferes with IL-1 mRNA translation. Importantly, no
cytotoxic effect of cytochalasin D and colchicine upon cultured
J774A.1 cells was observed as measured by an MTT assay (data
not shown) during which assay, these cells were treated with
various doses of cytochalasin D or colchicine, the results
indicating that colchicine inhibition of proIL-1 production
within J774A.1 cells was unlikely to be due simply to cell
damage.
Discussion
Herein we have demonstrated that an extract of G. lucidum
polysaccharides (EORP) was able to be used to modulate the
immune response of cultured J774A.1 macrophage by
enhancing CD14-mediated endocytosis and by increasing
TLR4-regulated IL-1 gene expression (Fig. 8). In essence, we
found that EORP increased the surface expression of both
CD14 and TLR4, and promoted LPS endocytosis, within such
macrophages. Moreover, EORP pretreatment increased the
level of LPS-induced IL-1 secretion in mice (In Vivo) as well as
within cultured human blood-derived primary macrophages,
and murine macrophage J774A.1 cells (in vitro). In addition, the
serum concentration of IL-1Ra was dramatically increased for
mice undergoing EORP injection, as compared to the basal level
of IL-1Ra release as revealed by analogous PBS injection. Of
importance here, we have demonstrated that CD14-mediated
LPS endocytosis and TLR4-regulated IL-1 gene expression
within J774A.1 cells are two separate and independent events.
To the best of our knowledge, at time of writing, the precise
mechanisms of EORP immuno-modulation of LPS-stimulated
macrophages at a cellular level would appear to be somewhat
unclear. The cellular uptake/clearance of certain bacteria and
bacterial components (e.g., LPS) would appear to be
predominantly performed by phagocytosis conducted by
macrophages, this being one of the most-important features of
the innate anti-bacterial immune response, and a feature which
necessitates specific recognition of certain bacteria or bacterial
components and endocytic pathways (Fearon and Locksley,
1996). The clearance of LPS by macrophages would appear to
be a critical step for these cells’ defence mechanism and one
that reduces the relative toxicity of LPS, while still preserving
Fig. 7. Inhibitors of endocytosis reduce LPS internalization by J774A.1 cells but not LPS dependent activation. A: Endocytosis inhibitors block
LPS internalization by J774A.1 cells. J774A.1 cells were pretreated with EORP (25 mg/ml) for 24 h, then washed with PBS, and treated with
cytochalasin D (10 mM), colchicines (30 mM) or vehicle control (DMSO) for 30 min, followed by FITC-LPS (green) treatment at 37-C for 1 h.
After fixation, cells were examined under confocal microscope. Part A: phase contrast images; (part B) fluorescent images; (part C) merged
images. B: Effect of endocytosis inhibitors onLPS-inducedMAPKs phosphorylation in J774A.1 cells. J774A.1 cellswere pretreated for 30minwith
cytochalasin D (1 and 10mM) or colchicine (10 and 30mM) before being exposed to LPS (1mg/ml) for 15min. Phosphorylation level of ERK, JNK,
and p38 were analyzed byWestern blotting with anti-diphosphorylated ERK, anti-diphosphorylated JNK, or anti-diphosphorylated p38
monoclonal antibody, respectively.Oneof threeexperiments is presented.C:Effect of endocytosis inhibitors onLPS-inducedproIL-1 production
within J774A.1 cells. J774A.1 cells were pretreated with cytochalasin D (1 and 10 mM) or colchicine (10 and 30 mM) for 30 min, followed by LPS
treatment for 6 h, and then whole cell lysates were analyzed for proIL-1 protein byWestern blotting. One of three experiments is presented. D:
Effect of endocytosis inhibitors on LPS-induced IL-1 mRNA expression within J774A.1 cells. J774A.1 cells were pretreated for 30 min with
cytochalasinD(1and10mM)orcolchicine(10and30mM)beforebeingexposedtoLPS(1mg/ml)for1h.IL-1mRNAexpressionwereanalyzedbyRT-
PCR. One of three experiments is presented. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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Fig. 8. The proposed mechanism of Ganoderma lucidum polysaccharides enhances the modulation of CD14/TLR4-mediated endocytosis and
signaling in IL-1 cytokine expression.
548 H U A E T A L .some of these agents’ potentially beneficial inflammation-
related immune response-triggering stimuli (Munford and Hall,
1986). LPS is able to be recognized by various macrophage-cell
surface molecules such as TLR4, CD14 (Wright et al., 1990),
and/or MSR (Hampton et al., 1991). In our current study, we
have demonstrated that LPS decreased TLR4 surface
expression for cultured J774A.1 macrophage cells, but
increased the cell-surface expression of MSR, an outcome
which could explain the reason for the observation herein that
LPS pretreatment did increase LPS uptake by cultured
macrophages, albeit only slightly; whereas, by contrast, EORP
down-regulated the surface expression of MSR, but significantly
up-regulated the surface expression of both TLR4 and CD14.
Moreover, it would appear that EORP (F3), but not the related
fractions ofG. lucidum polysaccharides, F1 and F2, increased LPS
binding to J774A.1 cells and uptake by J774A.1 cells. Using the
TLR4 and CD14 blocking antibodies, which block TLR4 and
CD14 binding to their ligands, we were able to demonstrate
that CD14 is crucial for LPS binding to J774A.1 cells and uptake
by J774A.1 cells, although surface expression of TLR4 does not
correlatewell with the level of such LPS binding to J774A.1 cells.
Such an outcome suggests that in the presence of LPS, TLR4 is
only involved with LPS-mediated signaling but has nothing to do
with LPS binding and uptake by J774A.1 cells, a result which
would appear to be entirely consistent with the results of
certain other related studies (Dunzendorfer et al., 2004).
Although CD14 plays an important role in the process of LPS
binding and uptake by J774A.1 cells, the presence of CD14
blocking antibody in culture does not completely inhibit EORP-
enhanced LPS binding and uptake by J774A.1 cells, suggesting
that certain specific mechanism(s) are involved in this specific
process.
In addition to J774A.1 cells activation, membrane-bound CD14
plays another important role within the spectre of endocytosis,
a role that requires cytoskeleton rearrangements andJOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPpolymerization (Latz et al., 2002; Dunzendorfer et al., 2004). In
order to distinguish between the EORP-mediated increase of
LPS uptake by J774A.1 cells as occurring through a passive-entry
process either across or through a CD14-dependent classical
form of endocytosis, we utilized certain drugs known to inhibit
cytoskeleton polymerization such as cytochalasin D and
colchicine. From such investigation, we found that both
cytochalasin D (Cooper, 1987) (blocking actin polymerization)
and colchicine (Isowa et al., 1999) (blocking microtubule
polymerization) significantly reduced the level of endocytosis of
FITC-LPS, but elicited no interference with LPS-induced IL-1
mRNA expression, indicating that the two processes,
endocytosis and signal transduction, are normally independent.
In addition, cytochalasin D was noted to increase the level of
LPS-induced proIL-1 production, as well as increasing the level
of ERK, JNK, and p38 activation. We propose, thus, that the
cytochalasin D disruption of actin polymerization prompts one
certain type of stress for J774A.1 cells, and is a process which
intervenes in the propagation of mitogenic and/or activation
signals (Zigmond, 1996). By contrast, colchicine selectively
enhanced LPS-induced p38 activation, but diminished proIL-1
production at a high concentration, suggesting that colchicine
inhibits certain proIL-1/IL-1 protein translation processes
(Bocker et al., 2001).
The acquired hyper-responsiveness of IL-1 gene expression via
EORP is characterized by the increased ability of LPS to
stimulate steady-state levels of IL-1 mRNA, proIL-1 protein, IL-
1 secretion, and MAPK activation, but not the ICE activity level
(data not shown) within cultured J774A.1 cells. Further, such
LPS stimulation also encompasses the enhancement of the
serum level of IL-1 secretion, in vivo, formice that have been i.p.
injected with LPS. The increasing level of EORP-mediated up-
regulation of IL-1 secretion by J774A.1 cells was observed to be
more substantial than the corresponding level increase of the
proIL-1 protein. In our previous study, we found that EORP is
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pre-treatment induced tolerance towards LPS on LPS-induced
TNF secretion (data not shown); however, EORP does not
induce LPS tolerance on LPS-induced IL-1 expression. We
suggest that there are several active compounds in the extract
of Reishi polysaccharides and that the enhancing effects we
observed cannot be explained by our previous reports that
EORP stimulates cells through TLR4. There would be some
active compounds in EORP that specific enhance IL-1 gene
expression, yet some compounds would induce tolerance
toward LPS on TNF secretion, and comprehension of the
details of such a mechanism clearly warrant further
investigation. In order to gain further insight into the
mechanism of the EORP-mediated up-regulation of
LPS-induced IL-1 gene expression, we examined the protein
expression of extracellular and intracellular signaling molecules
involved in the TLR4-mediated signaling pathways. We,
previously, have reported that LPS stimulates ERK, JNK, and
p38 activationwithin J774A.1 cells (Hsu andWen, 2002); herein
we have demonstrated that pre-exposure of such cells to EORP
dramatically increases the LPS induction of ERK, JNK, and p38
activation. By contrast, however, LPS pretreatment if J774A.1
macrophages appears to induce a state of cellular
hyporesponsiveness to subsequent challenge with LPS, leading
to a significant suppression of ERK, JNK, and p38 activation
within certainmacrophages, such an outcomebeing termed LPS
tolerance (Dobrovolskaia et al., 2003; Karahashi and Amano,
2003; Leesun et al., 2004). Using inhibitors of the activation of
certain MAPKs, we have demonstrated that SP600125 (JNK
inhibitor) and SB203580 (p38 inhibitor), but not PD98059
(MEK1 inhibitor), inhibit the EORP-mediated up-regulation of
proIL-1 protein production, indicating that EORP up-regulation
of proIL-1 protein results, principally, from the enhanced
activation of JNK and p38. Moreover, we also found that EORP
stimulation of cultured J774A.1 macrophages led to a rapid
degradation of IRAK-1 protein in cytosol and the slight down-
regulation of the expression of IRAK-2 and IRAK-M (data not
shown). Further, such EORP stimulation also led to the
retention of a similar steady-state level of the protein MyD88
(data not shown). Since IRAK-M has been reported to be an
important negative regulator of LPS-mediated signal
transduction related to cytokines expression (Kobayashi et al.,
2002), our results appear to suggest that the EORP-mediated
enhancement of IL-1 gene expression followed by LPS challenge
is probably, at least partially, due to the associated reduction in
IRAK-M expression by EORP treatment. IL-1 released from
activated macrophages has been reported to be one of the
more-important reactions in the innate immune response of
mice (Yamada et al., 2000).
It has been reported previously that the administration of IL-1
protected mice from lethal E. coli infection as compared to
untreated mice (Joshi et al., 2002). Herein, we have
demonstrated that EORP pretreatment enhances LPS-induced
IL-1 secretion by macrophages for mice, as well as enhancing
LPS-induced IL-1 secretion by cultured human primary
macrophages, and J774A.1 cells in vitro, a scenario which may
provide some form of protection effect for host species in
response to pathogen challenge. Although EORP was observed
to increase LPS-induced IL-1 expression, interestingly, EORP
also dramatically enhanced IL-1Ra secretion by C57BL/6J mice
within 3 h of LPS i.p. injection. Since IL-1Ra is a member of the
IL-1 superfamily, the actions of which include the competitive
inhibition of the binding of IL-1 to an IL-1 receptor (IL-1R)
(Hannumet al., 1990), the current ‘‘parallel’’ EORP regulationof
IL-1 and IL-lRa could, in fact, be part of a mechanism designed to
preserve the level of access of IL-1 to IL-1R (Arend et al., 1998).
The increase in the serum level of IL-lRa for EORP-treatedmice
and cultured macrophages would appear to reduce the
availability of the IL-1 to IL-1 receptor; therefore, the netJOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCPreaction may be to shift the biological functions of IL-1 back
toward baseline.
It has been reported previously that intraperitoneal injection of
LPS is more lethal for IL-1Ra knockout mice than for normal
mice (Hirsch et al., 1996). Moreover, compared to normal mice
or IL-1Ra transgenicmice,mice lacking endogenous IL-1Ra have
been shown to be less susceptible to infection with Listeria
monocytogenes than is the case of control mice, such an
observation supporting the notion of the relative importance of
IL-1 as regards imparting resistance to infection with
intracellular organisms for mice. Conversely, IL-lRa
overproducers are protected from the lethal effects of LPS but
appear to be more susceptible to listeriosis than is the case of
controlmice. Serum levels of IL-1 following an LPS challenge are
reduced for IL-lRa nulls and increased for IL-lRa overproducers
when compared to corresponding levels for control individuals
(Hirsch et al., 1996). Our current results which suggest that the
concentration of IL-1Ra in serum and conditioned medium
deriving from, respectively, EORP-stimulated mice and
macrophages, was substantially larger than corresponding
levels for controls, such an outcome likely leading to an increase
of serum and supernatant of cultured cells in the level of soluble
IL-1 (non-receptor bound IL-1) during LPS stimulation. The
balance between endogenous IL-1 and IL-1Ra is, thus, important
in influencing the host response to micro-organisms infection
or abnormal inflammation (Hirsch et al., 1996). Hence, the
outcomes of certain IL-1-mediated processes may be
dependent upon the relative inherent endogenous quantities of
IL-1 and IL-lRa, rather than upon the absolute quantity of IL-1 in
serum of mice or supernatant of cultured cells alone.
In summary, we have demonstrated that EORP increases
surface expression of CD14 and TLR4, respectively, and
enhances CD14-dependent binding and endocytosis of LPS for
cultured murine macrophage cells. On the other hand, EORP
promotes the TLR4-mediated hyper-responsiveness of IL-1
gene expression and the activation of MAPKs for cultured
macrophages subsequent to LPS challenge. In addition, EORP
challenge dramatically increases IL-1Ra expression bymice. The
results of endocytosis-inhibitor blockade of LPS internalization
in the absence of any apparent interference with LPS-
dependent activation for J774A.1 macrophages indicate that
these two outcomes are independent. In the first instance, our
current results have provided an understanding of mechanisms
of the EORP-mediated up-regulation of IL-1 gene expression
and the enhancement of LPS endocytosis, an insight, which is
relevant to EORP as regards the modulation of the normal
antibacterial immune response and the clearance of bacteria or
related components from the host.
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